Unmet Needs and Therapeutic Strategies in Cardio-Hemato-Oncology

Abstract

With the increasing survival of cancer patients and therapeutic advancements, the cardiovascular complications of therapy have become a significant issue. A dedicated, integrated team is important in providing the balance between acquiring a hematological/oncological response and cardiovascular morbidity and mortality. This article aims to shed light on this field – providing some examples of therapies with cardiotoxic potential as well as the cardiologist’s approach to patient assessment before, during, and after therapy.